Výsledky vyhledávání - "P. Ibarra de Palacios"

Akademický článek

Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants

Autor: Megumi Inoue, Tetsuro Ogawa, Hiroshi Tamura, Yosuke Hagiwara, Yuki Saito, Darren Abbanat, Germie van den Dobbelsteen, Peter Hermans, Stefan Thoelen, Jan Poolman, Patricia Ibarra de Palacios

Publikováno v: Human Vaccines & Immunotherapeutics, Vol 14, Iss 9, Pp 2150-2157 (2018)

This Phase 1, randomized, double-blind, placebo-controlled study was conducted to evaluate the safety, tolerability and immunogenicity of different doses of ExPEC4V conjugate vaccine (4-16µg Polysaccharide [PS]/serotype) in healthy Japanese particip

Externí odkaz: https://doaj.org/article/3d23f7a5c4eb41e297ef09fea55d7ac9

Zobrazit plný text záznamu

O-serotype distribution of Escherichia coli bloodstream infection isolates in critically ill patients in The Netherlands

Autor: B. Morrow, Todd A. Davies, Olaf L. Cremer, Elisabeth Roberts, Marc J. M. Bonten, P. Ibarra de Palacios, Diana M. Verboom, Meri R.J. Varkila, Edward G. Dudley, Peter Hermans, Jan Poolman

Publikováno v: Vaccine. 39(12)

Objectives Invasive infections by extra-intestinal pathogenic Escherichia coli (ExPEC) strains are increasing. We determined O-serogroups of E. coli isolates from ICU patients having bloodstream infections (BSI) and the potential coverage of a 10-val

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7093a746d33cf35406de2ed39d9bfffe
https://pubmed.ncbi.nlm.nih.gov/33642161

Zobrazit plný text záznamu

Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study

Autor: G. Schmidt, J. Heikkinen, Göran Samsioe, A Ehrenborg, P. Ibarra de Palacios, C Scheurer, E Boschitsch, Miguel Arguinzoniz, R Hobson, H Concin, C De Geyter

Publikováno v: Climacteric. 9:368-379

To establish whether transdermal continuous hormone replacement therapy (HRT) with estrogen/progestogen provides adequate long-term endometrial protection in postmenopausal women over a period of 96 weeks.This multicenter, randomized, open-label, par

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e52ee0547571baf143a7b8babc1043dc
https://doi.org/10.1080/13697130600953661

Zobrazit plný text záznamu

Plný text ve formátu HTML

Hormone replacement therapy and breast density changes

Autor: V V Ragavan, Erhard Quebe-Fehling, C Scheurer, J Harvey, P. Ibarra de Palacios, F T Kawakami

Publikováno v: Climacteric. 8:185-192

To compare the incidence of increased breast density and tenderness in postmenopausal women associated with transdermal (Estalis/Combipatch), Novartis, Basel, Switzerland) and oral (Kliogest), Schering AG, Berlin, Germany) hormone replacement therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d665f0491782991f965dc50d769cf858
https://doi.org/10.1080/13697130500103458

Zobrazit plný text záznamu

Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen

Autor: M. Freue, H.B. Willemse, C. Boni, Fritz Jänicke, J. Joliver, S. Van Belle, M. Kjaer, P. Ibarra de Palacios, R.C. Coombes, J. Zieschang, R. Pérez-Carrión, Carsten Rose

Publikováno v: The Breast, 9(1), 9-16. Churchill Livingstone

The aim of the trial was to compare efficacy and safety of the aromatase inhibitor formestane (250 mg i.m. given every 2 weeks) with the progestin megestrol acetate (160 mg administered orally once daily), as second-line therapy in postmenopausal pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4caf194ee1673a2e8544d8ce6388bbc3
https://doi.org/10.1054/brst.1999.0118

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání